Ariad Pharmaceuticals, Inc. Announces Data Presentations and Webcast of Investor Briefing at the 2013 American Society of Clinical Oncology Annual Meeting

Published: May 16, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig® (ponatinib) and AP26113, its investigational inhibitor of anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR) and c-ros oncogene (ROS1), will be presented at the Annual Meeting of the American Society of Clinical Oncology being held in Chicago, May 31 to June 4, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news